Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEISB.L Regulatory News (EISB)

  • There is currently no data for EISB

Year-End Trading Update

22 Feb 2024 07:00

RNS Number : 0038E
East Imperial PLC
22 February 2024
 

 

22 February 2024

East Imperial plc

("East Imperial" or the "Company")

 Year-End Trading Update

East Imperial plc, the global purveyor of super-premium beverages, is pleased to provide an update on trading for the year ended 31 December 2023.

Highlights

? Revenue of £2.35m for FY2023 (unaudited), as expected behind the £3.17m recorded in FY 2022 given the operating constraints experienced in Q2 and Q3

? Post resolution of operational issues, sales recovery in Q4 2023 with momentum maintained in Q1 2024

? Margin improvement programme implemented in Q4 2023, which included cost reduction initiatives and selective price rises, led to a 15% margin expansion in Q4 2023 and improvement maintained into 2024

? Implementing initiatives to improve working capital cycle including the moving of overseas customers to FOB shipping terms and trade financing

? Ongoing discussions with potential debt funders to provide additional working capital to help support ongoing expansion

? Expectation that cashflow breakeven will be achieved in Q4 2024

 

As previously announced, 2023 was a challenging year for the business, as a shortage of working capital in Q2 and Q3 affected operations and revenue until the Convertible Loan Note facility from INL was agreed upon and then drawn down in August and November 2023.

 

Significant progress has been made to restructure the business since the inflow of the loan proceeds with a focus on cost reductions, margin improvement and Tier 1 and Tier 2 customer wins. In Q4 2023, these efforts began to gain traction as the on-premises and off-premises channels recovered in the New Zealand market, with over 44,000 cases shipped, representing approximately £533,000 in revenue from New Zealand alone. Overall, the revenue for the year was £2.35m (2022: £3.17m), reflecting the five-month working capital constraints and the loss of capacity in Q2 and Q3.

 

The Company has now established an experienced US sales team in key strategic regions - initially in Florida, California and Texas, which is driving sales growth in 2024.

Singapore remains an important regional gateway in Asia, and the Company's regional distribution partner strengthens market access to ASEAN markets here and in Hong Kong.

In mainland China, sales growth in 2023 had been slower than expected. The Company has been working closely with its distributor to roll out a targeted development plan for this market for 2024. With the significant Tier 1 addition of Galaxy Entertainment Group in Macau and with approximately 6,000 cases expected to be shipped in Q1 2024, progress is being made.

Continued Tier 1 client wins in Europe, the Netherlands and the Czech Republic demonstrate the Company's ability to 'land and expand' its product range and compete with larger brands.

In addition to sales growth, increasing margins is important to accelerating the Company's path to breakeven. The margin improvement programme implemented in Q4 2023 includes a range of initiatives, including moving overseas customers to FOB shipping terms, reducing logistical touchpoints, and putting in place trade financing, in addition to cost reduction initiatives and selective price rises. In Q4, margins showed a 15% increase from Q3, and this improvement has been maintained in January 2024.

Overall, the direction in terms of sales and margins is positive and the Board remains confident in the team's ability to continue to deliver further Tier 1 and Tier 2 listings, drive growth, and deliver the case sales required in 2024 and beyond. The Company is in discussions with potential debt funders to provide additional working capital to support this growth.

The Company expects to announce its results for the year ended 31 December 2023 in April 2024.

Anthony Burt, CEO & Executive Chairman of East Imperial plc, commented:

 

"East Imperial made significant operational improvements and commercial advances during 2023 despite the challenging operational issues earlier in the year. We know that we must drive sales, margin enhancement and cash generation as we target customers in our chosen markets who demand quality and a sense of individuality. Our brand's strength and growth potential are unquestionable and are demonstrated by our recent and ongoing client wins."

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information, please contact:

East Imperial plc

Anthony Burt

 

investors@eastimperial.com

Allenby Capital Limited (Broker)

Guy McDougall / Matt Butlin (Sales and Corporate Broking)

Jeremy Porter / Piers Shimwell (Corporate Finance)

+44 (0)20 3328 5656

 

 

About East Imperial

 

Founded in New Zealand and Singapore in 2012, East Imperial produces a range of super-premium mixers that sell throughout APAC, the US and EMEA. Guided by a clear strategy to capitalise on the growing demand for premiumisation across the beverage industry, East Imperial has sold over 33 million bottles in over 20 countries since its founding, with popular products including Old World Tonic Water, Grapefruit Tonic Water, Yuzu Tonic Water and Mombasa Ginger Beer. In 2023, East Imperial won 8 medals at the coveted Tonic & Mixers Masters Competition in London.

 

The Company was founded on the philosophy of creating exquisite products defined by heritage, tradition, and authenticity. All products are made from the highest quality, all-natural ingredients, reflecting East Imperial's commitment to providing a sustainable product and minimising environmental impacts at every stage of the manufacturing process. For more information about East Imperial and its ultra-premium mixers.

 

Visit https://www.eastimperial.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTTBMPTMTBTBMI
Date   Source Headline
28th Aug 20242:09 pmRNSResult of GM and Creditors' Meeting
12th Aug 202411:43 amRNSNotice of General Meeting and Creditors' Meeting
31st Jul 20248:49 amRNSCompany update and intention to cancel listing
15th Apr 20247:57 amRNSSuspension of Share Trading
15th Apr 20247:30 amRNSSuspension - East Imperial plc
12th Apr 20244:42 pmRNSCorporate Update
11th Apr 20243:27 pmRNSUpdate re. potential funding sources
11th Apr 20247:00 amRNSResignation of Director
6th Mar 20247:00 amRNSInterview with Chief Executive Officer, Tony Burt
29th Feb 20249:32 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSDirectorsTalk Interview
22nd Feb 20247:00 amRNSYear-End Trading Update
19th Feb 20246:07 pmRNSResult of General Meeting
13th Feb 20247:00 amRNSContinued Global Account Wins in 2024
5th Feb 20247:00 amRNSPartnership with Galaxy Entertainment Group
2nd Feb 202412:19 pmRNSNotice of GM and Capital Reorganisation
2nd Feb 20247:00 amRNSManagement and Board changes
31st Jan 20245:00 pmRNSTotal Voting Rights
31st Jan 20247:00 amRNSHolding(s) in Company
24th Jan 20247:50 amRNSProposed Placing to raise approximately £325,000
3rd Jan 20247:00 amRNSNew Zealand Trading Update
13th Dec 20237:16 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSAppointment of Allenby Capital as Broker
13th Nov 20238:02 amRNSDirectorship Changes
7th Nov 20237:05 amRNSDirectorsTalk Interview
7th Nov 20237:00 amRNSSecond Completion - Secured Convertible Loan Notes
29th Sep 20237:10 amRNSInterim Results
29th Sep 20237:00 amRNSPartnership Agreement
6th Sep 20238:13 amRNSDirectorship Changes
22nd Aug 20237:14 amRNSAppointment of Key US Sales Resource
15th Aug 20237:40 amRNSHolding(s) in Company
14th Aug 202312:54 pmRNSFirst Completion - Secured Convertible Loan Notes
14th Aug 20237:00 amRNSHolding(s) in Company
10th Aug 20238:46 amRNSHolding(s) in Company
4th Aug 202311:18 amRNSResult of General Meeting
28th Jul 20237:00 amRNSAir New Zealand Partnership
19th Jul 202312:25 pmRNSNotice of GM
17th Jul 20237:00 amRNSFunding Update – issue of £2.2m Convertible Loan
30th Jun 202310:13 amRNSResult of AGM
6th Jun 20237:55 amRNSPosting of Annual Report and Notice of AGM
2nd May 20237:00 amRNSAudited Full-Year Results
13th Apr 20237:00 amRNSBoard Change
17th Feb 202310:26 amRNSHolding(s) in Company
9th Feb 20232:05 pmRNSSecond Price Monitoring Extn
9th Feb 20232:00 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSPre-Close Trading Statement
13th Jan 202310:00 amRNSTR-1: Notification of Major Holdings
8th Dec 20227:00 amRNSVietnam Distribution Agreement
24th Nov 20229:06 amRNSSecond Price Monitoring Extn
24th Nov 20229:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.